SALT LAKE CITY, Aug. 28, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2024. Fourth Quarter Fiscal 2024 Summary*: Revenue of $48.9 million, a decrease of 9.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was do ...

SALT LAKE CITY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the appointment of Rajendran Anbalagan to the Company's Board of Directors effective today. The appointment comes after the Board conducted a comprehensive search to identify a candidate with transformational digital skills and identified Mr. Anbalagan as an exceptional choice. "We are very ...

SALT LAKE CITY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, recently hosted its exclusive Rise Retreat in Park City, UT. The event brought together top enrolling Independent Consultants for a weekend blending leisure, adventure and strategic collaboration, with the event serving as an exclusive preview for the Company's upcoming product launch. Held from Augu ...

SALT LAKE CITY, Aug. 14, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2024, after the stock market closes on Wednesday, August 28, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. I ...

SALT LAKE CITY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced an exciting refresh to its Rewards Circle Customer loyalty program in its U.S., Australia and New Zealand markets. This comprehensive update introduces new benefits and enhancements designed to provide greater value and optimize engagement for Customers, while also adding Subscription ...

The Open House call on the 23rd will feature a Q&A with LifeVantage President and CEO, Steve Fife, Chief Sales Officer, Kristen Cunningham, and Regional Vice President of Sales, Jake Hines. The discussion will include the evolution of the Company and how LifeVantage has positioned itself for future growth in direct sales. Consumer advocate, environmental champion, business leader, and LifeVantage Board Member, Erin Brockovich, will also join the call to share what attracted her to the Company, as well as gi ...

SALT LAKE CITY, July 22, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, held its global Activate 2024 virtual event on Saturday, July 20, 2024. The event, supported by Consultant-hosted watch parties and local gatherings, served as a platform to reaffirm its commitment to the direct selling industry as it looked back at several years of transformation to leapfrog the com ...

"LV360 enabled us to evolve into a company poised to meet the needs of individuals sharing their commitments to health and wellness through incredible activation products as well as entrepreneurs looking to build and grow successful businesses," said Steve Fife, President and CEO. "And as rewarding as the past several years have been, the best is yet to come thanks to our thriving community. Activate 2024 celebrated LifeVantage, past, present and future." "This product introduction will be a game-changer fo ...

Date: Thursday, June 6, 2024 Presentation time: 2:00pm ET Location: Convene – 810 7th Ave., NYC – 23rd Floor Registration: MicroCap Rodeo - Spring into Summer | Registration Webcast link: https://www.webcaster4.com/Webcast/Page/3045/50680 Management will be available for one-on-one meetings at each conference and a live webcast of each presentation will be accessible on the News & Events section of the Company's Investor Relations website at https://lifevantage.gcs-web.com/. Shortly following each presentat ...

财务数据和关键指标变化 - 第三季度收入为4.82亿美元,同比下降10.2%,其中美洲地区收入下降5.9%,亚太及欧洲地区收入下降22.4% [37][38][39][40] - 毛利率为78.9%,同比下降1.3个百分点,主要受产品结构变化、存货报废和制造成本上升的影响 [41] - 佣金和奖励费用占收入的比重下降340个基点至40.9%,主要受销售结构变化、促销活动时间和规模变化以及Evolve薪酬计划变化的影响 [42] - 非GAAP调整后的销售及一般管理费用下降1.9个百分点至31%的收入占比 [43] - 非GAAP调整后的营业利润为340万美元,同比增长112.5% [44] - 非GAAP调整后的净利润为280万美元,每股0.21美元,同比增长150% [44] - 第三季度税率为13.6%,同比下降25个百分点,主要受益于本季度确认的税收优惠 [45] - 非GAAP调整后的EBITDA为510万美元,同比增长55%,EBITDA利润率提升440个基点至10.5% [10][11][46] 各条业务线数据和关键指标变化 - 液体胶原蛋白产品收入超过1100万美元,同比增长约7%,占总收入的23% [30][31] - 美国市场液体胶原蛋白渗透率为27.8%,较上季度的31.6%有所下降,但仍高于上年同期的27.2% [31] - 美国市场客户液体胶原蛋白渗透率保持在27.2%的水平 [31] 各个市场数据和关键指标变化 - 美洲地区收入下降5.9%,主要受活跃账户下降13.9%的影响,但平均每户收入有所提升 [38] - 亚太及欧洲地区收入下降22.4%,主要受活跃账户下降17.1%、中国电商业务关闭以及汇率波动的负面影响 [39][40] - 日本市场表现疲弱,是拖累亚太及欧洲地区收入的主要原因 [57] - 菲律宾市场持续低于预期 [57] 公司战略和发展方向及行业竞争 - 公司持续优化LV360计划,重点提升新顾问的首次收入和留存率,以增加新增顾问的"注册者"数量 [13][14][16][17][18] - 公司推出"Rise ERA"主题和奖励计划,鼓励顾问注册、留存和晋升,并新增了区域性的奖励旅行 [19][20] - 公司在全球范围内推出升级版的TrueScience护肤品系列,进一步巩固其在创新护肤品领域的地位 [23][24][25] - 公司将Evolve薪酬计划和Rewards Circle客户忠诚度计划拓展至加拿大、墨西哥和欧洲市场 [32] - 公司持续关注资本配置和股东价值,在第三季度继续回购股票并提高了季度股息 [34] 管理层对经营环境和未来前景的评论 - 公司第三季度盈利能力持续改善,调整后EBITDA同比增长55%,利润率提升至10.5% [10][11] - 公司LV360计划持续推进,获得组织内部广泛参与和认可 [33] - 公司对日本市场和菲律宾市场仍保持乐观,并将继续优化相关策略 [57] - 公司预计2024财年收入将在2.02-2.05亿美元区间,调整后EBITDA在1.6-1.8亿美元区间,调整后每股收益在0.57-0.67美元区间 [52][53] - 公司有信心在未来实现调整后EBITDA利润率达到低个位数的目标 [53]